PL1861509T3 - Sposób predykcji przeżywalności bez progresji i przeżywalności całkowitej przy wizytach kontrolnych w trakcie terapii u pacjentów z rozsianym rakiem piersi wykorzystujący krążące komórki nowotworowe - Google Patents

Sposób predykcji przeżywalności bez progresji i przeżywalności całkowitej przy wizytach kontrolnych w trakcie terapii u pacjentów z rozsianym rakiem piersi wykorzystujący krążące komórki nowotworowe

Info

Publication number
PL1861509T3
PL1861509T3 PL05725638T PL05725638T PL1861509T3 PL 1861509 T3 PL1861509 T3 PL 1861509T3 PL 05725638 T PL05725638 T PL 05725638T PL 05725638 T PL05725638 T PL 05725638T PL 1861509 T3 PL1861509 T3 PL 1861509T3
Authority
PL
Poland
Prior art keywords
follow
time point
breast cancer
tumor cells
cancer patients
Prior art date
Application number
PL05725638T
Other languages
English (en)
Inventor
Jeffrey W Allard
Gerald V Doyle
Daniel F Hayes
Michael Craig Miller
Leon W M M Terstappen
Original Assignee
Janssen Diagnostics Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Diagnostics Llc filed Critical Janssen Diagnostics Llc
Publication of PL1861509T3 publication Critical patent/PL1861509T3/pl

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
PL05725638T 2005-03-14 2005-03-14 Sposób predykcji przeżywalności bez progresji i przeżywalności całkowitej przy wizytach kontrolnych w trakcie terapii u pacjentów z rozsianym rakiem piersi wykorzystujący krążące komórki nowotworowe PL1861509T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/US2005/008602 WO2006104474A2 (en) 2005-03-14 2005-03-14 A method for predicting progression free and overall survival at each follow-up time point during therapy of metastatic breast cancer patients using circulating tumor cells
EP05725638.0A EP1861509B1 (en) 2005-03-14 2005-03-14 A method for predicting progression free and overall survival at each follow-up time point during therapy of metastatic breast cancer patients using circulating tumor cells

Publications (1)

Publication Number Publication Date
PL1861509T3 true PL1861509T3 (pl) 2016-01-29

Family

ID=37053815

Family Applications (1)

Application Number Title Priority Date Filing Date
PL05725638T PL1861509T3 (pl) 2005-03-14 2005-03-14 Sposób predykcji przeżywalności bez progresji i przeżywalności całkowitej przy wizytach kontrolnych w trakcie terapii u pacjentów z rozsianym rakiem piersi wykorzystujący krążące komórki nowotworowe

Country Status (6)

Country Link
EP (1) EP1861509B1 (pl)
JP (1) JP2008533487A (pl)
CA (1) CA2600225C (pl)
DK (1) DK1861509T3 (pl)
PL (1) PL1861509T3 (pl)
WO (1) WO2006104474A2 (pl)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITBO20040420A1 (it) 2004-07-07 2004-10-07 Type S R L Macchina per taglio e formatura di piattine metalliche
ITBO20050481A1 (it) 2005-07-19 2007-01-20 Silicon Biosystems S R L Metodo ed apparato per la manipolazione e/o l'individuazione di particelle
US8173413B2 (en) 2005-08-11 2012-05-08 University Of Washington Separation and concentration of biological cells and biological particles using a one-dimensional channel
US7993821B2 (en) 2005-08-11 2011-08-09 University Of Washington Methods and apparatus for the isolation and enrichment of circulating tumor cells
ITBO20050646A1 (it) 2005-10-26 2007-04-27 Silicon Biosystem S R L Metodo ed apparato per la caratterizzazione ed il conteggio di particelle
ITTO20060226A1 (it) 2006-03-27 2007-09-28 Silicon Biosystem S P A Metodo ed apparato per il processamento e o l'analisi e o la selezione di particelle, in particolare particelle biologiche
MX2008015425A (es) 2006-06-02 2008-12-12 Pfizer Prod Inc Ensayo de celulas tumorales circulantes.
US20080050739A1 (en) 2006-06-14 2008-02-28 Roland Stoughton Diagnosis of fetal abnormalities using polymorphisms including short tandem repeats
US8372584B2 (en) 2006-06-14 2013-02-12 The General Hospital Corporation Rare cell analysis using sample splitting and DNA tags
US8841135B2 (en) 2007-06-20 2014-09-23 University Of Washington Biochip for high-throughput screening of circulating tumor cells
ITTO20070771A1 (it) 2007-10-29 2009-04-30 Silicon Biosystems Spa Metodo e apparato per la identificazione e manipolazione di particelle
EP2229441B1 (en) 2007-12-12 2014-10-01 The Board of Trustees of The Leland Stanford Junior University Method and apparatus for magnetic separation of cells
IT1391619B1 (it) * 2008-11-04 2012-01-11 Silicon Biosystems Spa Metodo per l'individuazione, selezione e analisi di cellule tumorali
US10895575B2 (en) 2008-11-04 2021-01-19 Menarini Silicon Biosystems S.P.A. Method for identification, selection and analysis of tumour cells
SG174459A1 (en) 2009-03-17 2011-10-28 Silicon Biosystems Spa Microfluidic device for isolation of cells
JP6017845B2 (ja) * 2011-06-10 2016-11-02 帝人ファーマ株式会社 Ｇｐｉアンカータンパク質欠損細胞の検出方法
ITTO20110990A1 (it) 2011-10-28 2013-04-29 Silicon Biosystems Spa Metodo ed apparato per l'analisi ottica di particelle a basse temperature
ITBO20110766A1 (it) 2011-12-28 2013-06-29 Silicon Biosystems Spa Dispositivi, apparato, kit e metodo per il trattamento di un campione biologico
RU2547561C1 (ru) * 2013-12-18 2015-04-10 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Ульяновский государственный университет" Способ прогнозирования пятилетней выживаемости пациенток с инфильтрирующим раком молочной железы путем определения суммарного балла злокачественности
US11371982B2 (en) 2016-01-19 2022-06-28 Tosoh Corporation Method of predicting patient prognosis using rare cells
JP7326764B2 (ja) 2018-03-09 2023-08-16 東ソー株式会社 腫瘍マーカーならびに腫瘍細胞を夾雑細胞と区別して回収および検出する方法
JP2019158777A (ja) * 2018-03-16 2019-09-19 東ソー株式会社 腫瘍マーカーならびに腫瘍細胞を夾雑細胞と区別して回収および検出する方法
JP7521750B2 (ja) * 2020-01-14 2024-07-24 学校法人杏林学園 上皮系マーカー陰性の腫瘍細胞を検出する方法
JP2023516885A (ja) 2020-01-29 2023-04-21 コーセプト セラピューティクス， インコーポレイテッド 選択的グルココルチコイド受容体モジュレーター（ｓｇｒｍ）及び抗体チェックポイント阻害剤による副腎皮質がん腫の処置
JP7593584B2 (ja) * 2020-03-10 2024-12-03 学校法人杏林学園 腫瘍細胞マーカー、および腫瘍細胞を検出または回収する方法
EP4208719B1 (en) * 2020-09-02 2024-10-30 Menarini Silicon Biosystems S.p.A. System, kit, method and process for handling a sample
CN113284612B (zh) * 2021-05-21 2024-04-16 大连海事大学 一种基于XGBoost算法的生存分析方法
US20250172565A1 (en) * 2022-03-23 2025-05-29 Universiteit Twente A magnetic micro-needle to isolate single immunomagnetically labeled cells

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5993388A (en) * 1997-07-01 1999-11-30 Kattan; Michael W. Nomograms to aid in the treatment of prostatic cancer
JP2002503814A (ja) * 1998-02-12 2002-02-05 イムニベスト・コーポレイション 循環ガン細胞の迅速かつ効率的な単離のための方法および試薬
AU2876900A (en) * 1999-02-10 2000-08-29 Cell Works Inc. Class characterization of circulating cancer cells isolated from body fluids andmethods of use
WO2003019141A2 (en) * 2001-08-23 2003-03-06 Immunivest Corporation Analysis of circulating tumor cells, fragments, and debris
JP4256265B2 (ja) * 2002-03-13 2009-04-22 ベーイーオー・メリュー 循環腫瘍細胞の検出および／または定量方法、およびその方法の早期診断、予後診断、および再発診断への使用、ならびにその方法の治療的処置の選択および評価への使用
EP1597353B1 (en) * 2003-02-27 2010-11-24 Veridex, LLC CIRCULATING TUMOR CELLS (CTC's): EARLY ASSESSMENT OF TIME TO PROGRESSION SURVIVAL AND RESPONSE TO THERAPY IN METASTATIC CANCER PATIENTS

Also Published As

Publication number Publication date
CA2600225C (en) 2016-06-28
WO2006104474A3 (en) 2007-02-22
JP2008533487A (ja) 2008-08-21
EP1861509B1 (en) 2015-09-09
WO2006104474A2 (en) 2006-10-05
CA2600225A1 (en) 2006-10-05
EP1861509A4 (en) 2010-04-14
EP1861509A2 (en) 2007-12-05
DK1861509T3 (da) 2015-12-07

Similar Documents

Publication Publication Date Title
PL1861509T3 (pl) Sposób predykcji przeżywalności bez progresji i przeżywalności całkowitej przy wizytach kontrolnych w trakcie terapii u pacjentów z rozsianym rakiem piersi wykorzystujący krążące komórki nowotworowe
IL173477A0 (en) Bispecific antibodies for inducing apoptosis of tumor and diseased cells
ZA200610132B (en) Therapy of platinum-resistant cancer
ZA200702973B (en) Disubstituted pyrazolobenzodiazepines useful as inhibitors for CDK2 and angiogesis, and for the treatment of breast, colon, lung and prostate cancer
AU2003235618A8 (en) Ultrasonic treatment of breast cancer
IL227841A0 (en) Dihydropyridinones for the treatment of cancer
SG11202103913WA (en) Method for quantifying molecular activity in cancer cells of a human tumour
ZA200803517B (en) Methods for prediction and prognosis of cancer, and monitoring cancer therapy
IL190852A0 (en) Methods for prediction and prognosis of cancer, and monitoring cancer therapy
PL1827441T3 (pl) Kombinacje do leczenia chorób związanych z proliferacją komórek
ZA200804509B (en) Methods for prediction and prognosis of cancer, and monitoring cancer therapy
IL190871A0 (en) Methods for prediction and prognosis of cancer and monitoring cancer therapy
ZA200705059B (en) Cancer treatment method
IL313224A (en) CEA test to select patients in cancer treatment
SI1766056T1 (sl) Oligonukleotidi za diagnozo raka na prsih
AU2003217397A8 (en) Claudins, markers for diagnosis, prognosis and therapy of breast, bone, brain cancer
GB0512299D0 (en) Diagnosis prognosis and prediction of recurrence of breast cancer
EP1789082A4 (en) CYTOKINEXPRIMATING CELLULAR VACCINE FOR THE TREATMENT OF PROSTATE CANCER
IL179323A0 (en) Cancer treatment method
CY1117701T1 (el) Δραστηριοτητα του τέμσιρολιμου κατα των ογκων στον καρκινο θηλοειδων νεφρικων κυτταρων
GB0326578D0 (en) Cancer diagnosis and therapy
ZA200703482B (en) B7-H1 and methods of diagnosis, prognosis, and treatment of cancer
IL179359A0 (en) Cancer treatment method
DK1962094T3 (da) Detektionsmiddel og terapeutisk middel til højmalign brystcancer
FI20022304A0 (fi) Mammografialaitteisto rintasyövän edistykselliseksi havaitsemiseksi